nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—HSD3B1—connective tissue—skin cancer	0.103	0.131	CbGeAlD
Trilostane—HSD3B1—skin of body—skin cancer	0.0929	0.118	CbGeAlD
Trilostane—HSD3B1—mammalian vulva—skin cancer	0.0848	0.108	CbGeAlD
Trilostane—HSD3B1—female reproductive system—skin cancer	0.0726	0.0922	CbGeAlD
Trilostane—HSD3B2—female reproductive system—skin cancer	0.0575	0.0731	CbGeAlD
Trilostane—HSD3B2—head—skin cancer	0.048	0.061	CbGeAlD
Trilostane—ESR2—neck—skin cancer	0.0371	0.0472	CbGeAlD
Trilostane—ESR1—blood vessel—skin cancer	0.0355	0.0452	CbGeAlD
Trilostane—HSD3B2—lymph node—skin cancer	0.0336	0.0427	CbGeAlD
Trilostane—HSD3B1—Corticotropin-releasing hormone—KRT14—skin cancer	0.0323	0.152	CbGpPWpGaD
Trilostane—ESR2—connective tissue—skin cancer	0.0266	0.0338	CbGeAlD
Trilostane—ESR1—neck—skin cancer	0.0254	0.0323	CbGeAlD
Trilostane—ESR2—epithelium—skin cancer	0.0253	0.0321	CbGeAlD
Trilostane—HSD3B2—Corticotropin-releasing hormone—KRT14—skin cancer	0.0245	0.115	CbGpPWpGaD
Trilostane—ESR2—lymphoid tissue—skin cancer	0.0195	0.0247	CbGeAlD
Trilostane—ESR2—female reproductive system—skin cancer	0.0188	0.0238	CbGeAlD
Trilostane—ESR1—connective tissue—skin cancer	0.0182	0.0231	CbGeAlD
Trilostane—ESR1—epithelium—skin cancer	0.0173	0.022	CbGeAlD
Trilostane—ESR2—head—skin cancer	0.0157	0.0199	CbGeAlD
Trilostane—ESR1—lymphoid tissue—skin cancer	0.0133	0.0169	CbGeAlD
Trilostane—ESR1—female reproductive system—skin cancer	0.0129	0.0163	CbGeAlD
Trilostane—ESR2—Ovarian Infertility Genes—MLH1—skin cancer	0.0128	0.0599	CbGpPWpGaD
Trilostane—ESR2—lymph node—skin cancer	0.011	0.0139	CbGeAlD
Trilostane—ESR1—head—skin cancer	0.0107	0.0136	CbGeAlD
Trilostane—ESR1—lymph node—skin cancer	0.00752	0.00955	CbGeAlD
Trilostane—HSD3B1—Corticotropin-releasing hormone—BRAF—skin cancer	0.00717	0.0337	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00706	0.0332	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.00696	0.0327	CbGpPWpGaD
Trilostane—ESR2—Ovarian Infertility Genes—CDK4—skin cancer	0.00648	0.0305	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—XRCC1—skin cancer	0.00647	0.0304	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—BRAF—skin cancer	0.00543	0.0255	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00535	0.0252	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—SHH—skin cancer	0.0052	0.0244	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—BRAF—skin cancer	0.00377	0.0177	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—XRCC3—skin cancer	0.0032	0.015	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.00319	0.015	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PLIN2—skin cancer	0.00315	0.0148	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.00302	0.0142	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	0.00296	0.0139	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CDK4—skin cancer	0.00263	0.0124	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO4—skin cancer	0.0026	0.0122	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	0.00254	0.012	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CSPG4—skin cancer	0.00254	0.0119	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PLIN2—skin cancer	0.00238	0.0112	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—skin cancer	0.00217	0.0102	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	0.00216	0.0102	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MSH2—skin cancer	0.00206	0.00969	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CDKN2A—skin cancer	0.00201	0.00945	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CDK4—skin cancer	0.002	0.00942	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—TERT—skin cancer	0.002	0.00939	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CSPG4—skin cancer	0.00192	0.00903	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.00175	0.00821	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ENO2—skin cancer	0.00172	0.0081	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.00161	0.00755	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—FOXO4—skin cancer	0.00157	0.00739	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—skin cancer	0.00155	0.00731	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.00155	0.0073	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.00152	0.00716	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	0.00149	0.00701	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.00136	0.00639	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.00135	0.00634	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CDKN2A—skin cancer	0.00134	0.00628	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ENO2—skin cancer	0.00131	0.00614	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	0.00129	0.00608	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	0.00128	0.00603	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.00117	0.0055	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.00111	0.00522	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—skin cancer	0.0011	0.00516	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	0.00109	0.00513	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.00102	0.0048	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ERCC2—skin cancer	0.001	0.00471	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000994	0.00468	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RHOU—skin cancer	0.000993	0.00467	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CDK4—skin cancer	0.000945	0.00444	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BRAF—skin cancer	0.000836	0.00393	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000783	0.00368	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—skin cancer	0.00078	0.00367	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ERCC2—skin cancer	0.000759	0.00357	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—skin cancer	0.000743	0.00349	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000743	0.00349	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—skin cancer	0.000711	0.00334	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—skin cancer	0.00068	0.0032	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—HRAS—skin cancer	0.000673	0.00316	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.00066	0.0031	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTGS2—skin cancer	0.0006	0.00282	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000559	0.00263	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRAS—skin cancer	0.000522	0.00246	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTCH2—skin cancer	0.000485	0.00228	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTGS2—skin cancer	0.000455	0.00214	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.000452	0.00213	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—KRAS—skin cancer	0.00045	0.00211	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ERCC2—skin cancer	0.000442	0.00208	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000402	0.00189	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—HRAS—skin cancer	0.000382	0.0018	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000375	0.00176	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GLI2—skin cancer	0.000367	0.00173	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—skin cancer	0.000366	0.00172	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MC1R—skin cancer	0.000351	0.00165	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GLI1—skin cancer	0.000345	0.00162	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000333	0.00157	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SUFU—skin cancer	0.000327	0.00154	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SHH—skin cancer	0.00025	0.00117	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RASA1—skin cancer	0.000248	0.00117	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SMO—skin cancer	0.000237	0.00111	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTCH1—skin cancer	0.000237	0.00111	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTGER4—skin cancer	0.00023	0.00108	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ERCC2—skin cancer	0.000223	0.00105	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FOXO4—skin cancer	0.000204	0.000957	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TERT—skin cancer	0.000136	0.000639	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—BRAF—skin cancer	0.000108	0.000506	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRAS—skin cancer	6.77e-05	0.000318	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—KRAS—skin cancer	5.82e-05	0.000274	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—skin cancer	5.18e-05	0.000243	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HRAS—skin cancer	4.95e-05	0.000233	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—skin cancer	4.74e-05	0.000223	CbGpPWpGaD
